An ICU-grade breathable cardiac electronic skin for health, diagnostics, and intraoperative and postoperative monitoring.
Summary
This work introduces BreaCARES, a breathable electronic skin that delivers ICU-grade, real-time, wireless cardiac monitoring suitable for outpatient diagnostics, intraoperative stability during cardiac surgery, and continuous postoperative care. It reports superior anti-interference stability, portability, and long-term biocompatibility compared with commonly used clinical/commercial cardiac monitors.
Key Findings
- Developed a breathable cardiac electronic skin (BreaCARES) enabling real-time, wireless, continuous cardiac monitoring with ICU-grade accuracy.
- Demonstrated stable intraoperative monitoring during heart surgery and continuous, comfortable postoperative monitoring.
- Reported superior anti-interference stability, portability, and long-term on-skin biocompatibility compared with clinical/commercial ICU cardiac monitors.
Clinical Implications
Potential to reduce lead-related artifacts and skin injury, expand monitoring to ambulatory and ward settings with fewer wires, and provide stable intraoperative cardiac signals—especially valuable in cardiac anesthesia and postoperative telemetry.
Why It Matters
A wearable demonstrating ICU-grade accuracy across perioperative contexts could transform patient monitoring workflows and enable safer, more comfortable long-term cardiac surveillance. The platform bridges engineering, perioperative monitoring, and digital health.
Limitations
- Abstract does not provide detailed sample sizes or controlled comparative outcome metrics (e.g., clinical endpoints)
- Lack of randomized clinical trials demonstrating outcome benefits
Future Directions
Conduct randomized or prospective comparative studies to demonstrate reductions in perioperative monitoring failures, skin complications, and to validate signal quality across diverse surgeries and patient populations.
Study Information
- Study Type
- Case series
- Research Domain
- Diagnosis
- Evidence Level
- IV - Translational device development with application demonstrations; no randomized clinical outcomes.
- Study Design
- OTHER